Literature DB >> 2580573

The carbohydrate specificities of the monoclonal antibodies 29.1, 455 and 3C1B12 to the epidermal growth factor receptor of A431 cells.

H C Gooi, E F Hounsell, I Lax, R M Kris, T A Libermann, J Schlessinger, J D Sato, T Kawamoto, J Mendelsohn, T Feizi.   

Abstract

Sixteen hybridoma-derived antibodies to the epidermal growth factor receptor of A431 cells were studied with respect to their reactions with blood group-related carbohydrate structures. Twelve of these were assessed as recognizing carbohydrate determinants on the basis of their immunostaining of reference blood group substances on nitrocellulose paper. Three of these antibodies were further investigated by inhibition of binding assays with glycoproteins and structurally defined oligosaccharides or by haemagglutination of erythrocytes before and after treatment with endo-beta-galactosidase. Two of the antibodies, 29.1 and 455, were shown to have blood group A-related specificities which differed from one another and from those of monoclonal anti-A antibodies described previously. The third antibody, 3C1B12, which was shown to recognize a determinant based on alpha 1----3 fucosylated Type 2 chains on linear and branched backbone sequences, also differs from previously described monoclonal antibodies of 3-fucosyl-N-acetyllactosamine type, such as anti-SSEA-1 (anti-mouse embryo) and several antibodies to human myeloid cells. While these antibodies are invaluable in providing structural information on the carbohydrate chains of the receptor glycoprotein and should help to elucidate their functions, their use as 'anti-receptor' reagents in cell biology will be influenced by the knowledge that the determinants they recognize are shared by other glycoproteins and glycolipids of diverse cell types.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2580573     DOI: 10.1007/bf01117444

Source DB:  PubMed          Journal:  Biosci Rep        ISSN: 0144-8463            Impact factor:   3.840


  10 in total

Review 1.  Monoclonal antibodies to epidermal growth factor receptors in studies of receptor structure and function.

Authors:  T Kawamoto; G H Sato; K Takahashi; M Nishi; S Taniguchi; J D Sato
Journal:  Cytotechnology       Date:  1990-05       Impact factor: 2.058

2.  Ontogenic expression of histo-blood group antigens in the intestines of suckling pigs: lectin histochemical and immunohistochemical analysis.

Authors:  T P King; D Kelly
Journal:  Histochem J       Date:  1991-01

Review 3.  Carbohydrates as antigenic determinants of glycoproteins.

Authors:  T Feizi; R A Childs
Journal:  Biochem J       Date:  1987-07-01       Impact factor: 3.857

4.  Epidermal growth factor receptors in the oesophagus.

Authors:  J Jankowski; S Murphy; G Coghill; A Grant; K G Wormsley; D S Sanders; M Kerr; D Hopwood
Journal:  Gut       Date:  1992-04       Impact factor: 23.059

5.  The relationship between the expression of blood group-related antigens and the cell proliferation of pancreatic carcinomas induced by N-nitrosobis(2-oxopropyl)amine in hamsters.

Authors:  T Kobayashi; E Uchida; K Tamura; N Yamanaka
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

Review 6.  Interaction of antibodies with ErbB receptor extracellular regions.

Authors:  Karl R Schmitz; Kathryn M Ferguson
Journal:  Exp Cell Res       Date:  2008-10-22       Impact factor: 3.905

7.  Dynamic imaging of molecular assemblies in live cells based on nanoparticle plasmon resonance coupling.

Authors:  Jesse Aaron; Kort Travis; Nathan Harrison; Konstantin Sokolov
Journal:  Nano Lett       Date:  2009-10       Impact factor: 11.189

8.  EGFR-targeted hybrid plasmonic magnetic nanoparticles synergistically induce autophagy and apoptosis in non-small cell lung cancer cells.

Authors:  Tomohisa Yokoyama; Justina Tam; Shinji Kuroda; Ailing W Scott; Jesse Aaron; Tim Larson; Manish Shanker; Arlene M Correa; Seiji Kondo; Jack A Roth; Konstantin Sokolov; Rajagopal Ramesh
Journal:  PLoS One       Date:  2011-11-07       Impact factor: 3.240

9.  Signal transduction by epidermal growth factor occurs through the subclass of high affinity receptors.

Authors:  L H Defize; J Boonstra; J Meisenhelder; W Kruijer; L G Tertoolen; B C Tilly; T Hunter; P M van Bergen en Henegouwen; W H Moolenaar; S W de Laat
Journal:  J Cell Biol       Date:  1989-11       Impact factor: 10.539

10.  EGFR-targeted plasmonic magnetic nanoparticles suppress lung tumor growth by abrogating G2/M cell-cycle arrest and inducing DNA damage.

Authors:  Shinji Kuroda; Justina Tam; Jack A Roth; Konstantin Sokolov; Rajagopal Ramesh
Journal:  Int J Nanomedicine       Date:  2014-08-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.